Respiratory Distress clinical trials

Explore recruiting respiratory distress clinical trials.

Recruiting respiratory distress studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Respiratory Distress trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy of intravenous metoprolol in patients with Acute Respiratory Distress Syndrome (ARDS).

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Effectiveness of an Optimisation Strategy for Emergency Tracheal Intubation on postintubation Morbidity: A superiority cluster randomised controlled trial - OSETIM

France

Phase III and phase IV (Integrated) EU CTIS Study details

Potential of FX06 to improve disease severity in Acute Respiratory Distress Syndrome patients (Ixion 2.0)

Spain, France, Romania, Germany, Lithuania

Therapeutic exploratory (Phase II) EU CTIS Study details

APROTININ TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME: A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III TRIAL

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Duration of Surfactant administration and impact on Stabilisation of vital parameters in very preterm neonates: 1 minute versus 5 minutes – a prospective randomised-controlled phase IV trial

Austria

Therapeutic use (Phase IV) EU CTIS Study details

Phase 2, proof-of-concept, randomized, double-blinded, placebo-controlled, multicenter study to assess efficacy and safety of reparixin as add-on therapy to standard of care in adult patients with Acute Respiratory Distress Syndrome (RESPIRATIO)

Italy, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Respiratory Distress trials by city

Respiratory Distress in Toronto Respiratory Distress in Vancouver Respiratory Distress in Montreal Respiratory Distress in Calgary Respiratory Distress in Edmonton Respiratory Distress in Ottawa Respiratory Distress in Winnipeg Respiratory Distress in Quebec City Respiratory Distress in Hamilton Respiratory Distress in Kitchener Respiratory Distress in London Respiratory Distress in Halifax Respiratory Distress in New York Respiratory Distress in Los Angeles Respiratory Distress in Chicago Respiratory Distress in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease